Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sorafenib to Treat AML Patients With FLT3-ITD Mutation: a Non-interventional Cohort Study

NCT02156297 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Soochow University as lead sponsor.

NCT NCT02156297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02156297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sorafenib to Treat AML Patients With FLT3-ITD Mutation: a Non-interventional Cohort Study
Lead sponsor
The First Affiliated Hospital of Soochow University
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2014
Completion date
August 31, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, flt3-itd mutation